There’s going to be a lot of angst among physicians around the country over this, and quite understandably so. But we need to be part of the solution, and this is a potential part of the solution.
That’s what Mario E. Motta, MD, president of the Massachusetts Medical Society, says about the proposal for accountable care organizations to replace fee-for-service medicine in his state.
Read my article in Neurology Today to find out more.
Many proposals for a new way to pay health care providers are being considered, and all of them have critics.
Into this fray, the American Academy of Neurology Professional Association has proposed its own payment strategy that would provide bonus payments, based on quality reporting and care coordination – that might actually lower the cost of treating some neurologic patients while improving the care they receive.
Read my article in Neurology Today to find out details.
If it’s done correctly, I think subspecialists can do well in this mode.
That’s what Edward R. Jones, MD, president of Renal Physicians Association and a member of a six-physician practice in Philadelphia, thinks about the medical home concept.
Find out more about what the medical home may mean for subspecialists by reading my article in Nephrology Times.
Dawn Holcombe, executive director of the Connecticut Oncology Association and president of DGH Consulting, says oncologists need to pay more attention to the changes that are coming:
I worry that a lot of them don’t understand what they’re about to be hit with.
While many payment reform ideas are being tested, three concepts emerge in almost all of them. Find out what they are by reading my article in Oncology Times.
Now that America’s fee-for-service payment system has become the favored target for criticism for health care payers and policymakers, the search is on for its successor. One popular candidate: episode-based payment that transforms the way oncologists and other providers are paid for their work.
Read my article in Oncology Times to learn more.
I’ll look anyone straight in the eye and say, ‘This is certainly good for the insurer, very good for the patient, and economically good for the doctor. Why can’t we set something up where everyone does well, as opposed to everyone doing badly?
–Roy Beveridge, MD, Medical Director for US Oncology, describing his company’s new program, Innovent Oncology.
US Oncology, the nation’s largest chain of cancer clinics, and Cancer Clinics of Excellence, a group of independent clinics, both see clinical pathways as a key component of payment reform for oncologists. To learn more, read my article in Oncology Times.
This is harder than I initially thought it would be, and more important than I initially thought.
That’s what Bruce Cutter, MD, says about the development of clinical pathways for cancer care, one component of Cancer Care Northwest’s payment experiment with Premera Blue Cross.
Cancer Care Northwest, a 16-physician practice in Spokane, Washington, has been working with the area’s largest insurer, Premera Blue Cross, for six years to find a better way to deliver and pay for cancer care. Read my article in Oncology Times to find out more.